Arjan A van de Loosdrecht
12PUBLICATIONS
45CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|Sep 03, 2025
Computational measurable residual disease assessment in acute myeloid leukemia: a retrospective validation in the HOVON-SAKK-132 trial.Tim R Mocking, Lukas H Haaksma, Tom Reuvekamp
|May 22, 2025
Applications of machine learning for immunophenotypic measurable residual disease assessment in acute myeloid leukemia.Tim R Mocking, Arjan A van de Loosdrecht, Jacqueline Cloos
|Feb 27, 2025
CD34+CD38- leukemia stem cells predict clinical outcomes in acute myeloid leukemia patients treated non-intensively with hypomethylating agents.Tom Reuvekamp, Lok Lam Ngai, Daphne den Hartog
|Apr 29, 2024
Benefits and risks of clofarabine in adult acute lymphoblastic leukemia investigated in depth by multi-state modeling.Sjoerd J F Hermans, Yvette van Norden, Jurjen Versluis
|Mar 08, 2024
Myelodysplastic neoplasms dissected into indolent, leukaemic and unfavourable subtypes by computational clustering of haematopoietic stem and progenitor cells.Margot F van Spronsen, Sofie Van Gassen, Carolien Duetz
|Jan 31, 2024
Determinants of lenalidomide response with or without erythropoiesis-stimulating agents in myelodysplastic syndromes: the HOVON89 trial.A A van de Loosdrecht, E M P Cremers, C Alhan
Pageof 2
Frequent Collaborators
6 joint publications
Costa Bachas
5 joint publications
Jacqueline Cloos
5 joint publications
Lok Lam Ngai
4 joint publications
Tim R Mocking
4 joint publications
Thomas Pabst
3 joint publications
Bjørn T Gjertsen
3 joint publications
David C de Leeuw
3 joint publications
Markus G Manz
3 joint publications
Jesse M Tettero
2 joint publications
Johan A Maertens
